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This study identiﬁes SOX15 as a direct transcriptional
regulator of a substantial fraction of cell type-speciﬁc genes
in stratiﬁed epithelial cells. SOX15 expression is attenuated
in intestinal metaplasia (Barrett’s esophagus) but is active in
many esophageal adenocarcinomas.
BACKGROUND & AIMS: Intestinal metaplasia (Barrett’s
esophagus, BE) is the principal risk factor for esophageal
adenocarcinoma (EAC). Study of the basis for BE has centered
on intestinal factors, but loss of esophageal identity likely also
reﬂects the absence of key squamous-cell factors. As few de-
terminants of stratiﬁed epithelial cell-speciﬁc gene expression
have been characterized, identifying the necessary transcrip-
tion factors is important.
METHODS: We tested regional expression of mRNAs for all
putative DNA-binding proteins in the mouse digestive tract and
veriﬁed the esophagus-speciﬁc factors in human tissues and
cell lines. Integration of diverse data deﬁned a human squa-
mous esophagus-speciﬁc transcriptome. We used chromatin
immunoprecipitation with high-throughput sequencing (ChIP-
seq) to locate transcription factor binding sites, computational
approaches to proﬁle the transcripts in cancer data sets, and
immunohistochemistry to reveal protein expression.
RESULTS: The transcription factor Sex-determining region
Y-box 15 (SOX15) is restricted to esophageal and other murine
and human stratiﬁed epithelia. SOX15 mRNA levels are atten-
uated in BE, and its depletion in human esophageal cells
reduces esophageal transcripts signiﬁcantly and speciﬁcally.
SOX15 binding is highly enriched near esophagus-expressed
genes, indicating direct transcriptional control. SOX15 and
hundreds of genes coexpressed in squamous cells are reac-
tivated in up to 30% of EAC specimens. Genes normally
conﬁned to the esophagus or intestine appear in different cells
within the same malignant glands.
CONCLUSIONS: These data identify a novel transcriptional
regulator of stratiﬁed epithelial cells and a subtype of EAC with
bi-lineage gene expression. Broad activation of squamous-cell
genes may shed light on whether EACs arise in the native
stratiﬁed epithelium or in ectopic columnar cells. (Cell MolGastroenterol Hepatol 2015;1:598–609; http://dx.doi.org/
10.1016/j.jcmgh.2015.07.009)
Keywords: Barrett’s Esophagus; Esophageal Gene Regulation;
Esophageal Transcriptome; SOX15 Cistrome.
ntestinal metaplasia of the esophagus (Barrett’sIesophagus, BE) is a common, chronic condition in
which an epithelium containing intestinal goblet and other
columnar cells replaces the native stratiﬁed squamous
mucosa.1 BE results from chronic acid and bile reﬂux. Over
time, the metaplastic tissue may become dysplastic, and it
progresses to invasive cancer in three to ﬁve cases per 1000
person-years.2 Esophageal adenocarcinoma (EAC) arises
principally in the setting of BE, and the incidence of this
cancer in the West increased about eightfold between 1970
and 2010, with about 18,000 new U.S. cases and 15,000
deaths expected in 2015 (http://seer.cancer.gov).
Investigation into the mechanisms of BE has centered
largely on determinants of intestinal identity,3 particularly
the intestine-restricted transcription factors (TFs) Caudal
type homeobox 1 (CDX1) and CDX2, which specify the em-
bryonic intestine.4 Forced expression of CDX2 or CDX1 in
the mouse stomach induces ectopic intestinal differentia-
tion,5,6 and both factors are implicated in activating intes-
tinal genes in BE,7,8 though forced CDX2 expression in the
November 2015 SOX15 Control of Stratiﬁed Epithelial Genes 599mouse esophagus does not induce BE per se.9 Loss of
esophagus-speciﬁc transcripts and of stratiﬁed squamous
morphology probably reﬂects parallel loss of transcriptional
determinants of the native epithelium, which are largely
unknown. Tumor protein P63 (TP63) regulates differentia-
tion of all stratiﬁed epithelia, such as those in the esophagus
and skin,10,11 acting in part through another transcription
factor, basonuclin 1 (BNC1).12 Sex-determining region Y-box
2 (SOX2) controls esophageal differentiation in embryos13
and growth of adult progenitor cells,14,15 an activity in
which Kruppel-like factor 4 (KLF4) and KLF5 also may
participate.16 Forkhead box A2 (FOXA2) is expressed in
embryonic but not in adult esophageal cells.17 We sought to
identify other tissue-restricted TFs that might control the
characteristic stratiﬁed epithelium.
Among all putative DNA-binding proteins, we searched
ﬁrst for those with esophagus-restricted expression among
digestive epithelia and then for factors with attenuated
expression in BE. We identiﬁed sex-determining region
Y-box 15 (SOX15) as such a TF and we show that it directly
controls transcription of a large fraction of humanA
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Figure 1. Differential transcription factor (TF) expression in th
TFs in wild-type mouse digestive epithelia, as revealed in a quan
PCR) screen. Expression of 1880 TF mRNAs was assessed in e
stomach and intestine (blue). (B) TFs restricted to intestinal (I), s
over other tissues represented in shades of blue. (C) Relative
mRNAs in mouse tissues. The fold-excess values are represent
qRT-PCR for the six most highly esophagus-speciﬁc TF mRNAs
esophagus and of some factors in the skin.esophagus-expressed genes. SOX15 is absent from most
EACs, but up to 30% of cases retain expression of SOX15 and
its target genes, coexpressing representative intestinal and
squamous-speciﬁc genes within the same tissue. Together,
these data identify a novel regulator of stratiﬁed epithelial
genes and a subtype of EAC with bi-lineage gene expression.Materials and Methods
Tissue Preparation and Transcription Factor
Expression Screen
We isolated epithelial sheets from the esophagus, gastric
corpus-antrum, and duodenum of 1-month old CD1 and
C57BL/6 mice. Before peeling the mucosa using ﬁne forceps,
the esophagus was treated with 0.1% collagenase-dispase
(cat. no. 11097113001; Roche Applied Science, Indian-
apolis, IN) in phosphate-buffered saline (PBS) for 15 mi-
nutes at 37C, whereas stomach and duodenum were
incubated in 1 mM ethylenediaminetetraacetic acid (EDTA)
in PBS at 37C. To determine the relative transcript levels
(Figure 1A–C), we used quantitative reverse-transcriptionC
D
GAPDH
SIM2
PAX9
SOX15
TRIM29
ELF5
TCFAP2A
Bra
in
Th
ym
us
He
art
Lu
ng
Es
op
ha
gu
s
Sto
ma
ch
Int
es
tin
e
Liv
er
Sp
lee
n
Kid
ne
y
Mu
scl
e
Sk
in
Fold Increase
Versus SIM2 PAX9 SOX15 TRIM29 ELF5 TCFAP2A
Brain
Thymus
Heart
Lung
Stomach
Intestine
Liver
Spleen
Kidney
Muscle
Skin
 >1000  > 32
 > 500  >  2
 > 100  <  2
e normal mouse gut and other tissues. (A) Distribution of all
titative reverse-transcription polymerase chain reaction (qRT-
pithelial cell isolates from adult CD1 mouse esophagus (red),
tomach (S) or esophageal (E) epithelium, with the fold-excess
expression of Sim2, Pax9, Sox15, Trim29, Elf5, and Tcfap2a
ed in shades of color as indicated in the key. (D) Products of
in 12 adult mouse organs, showing selective expression in the
Figure 2. Differential transcription factor (TF) expression in normal and metaplastic human esophagus. (A) Expression
proﬁles of PAX9, SIM2, SOX15, and TRIM29 in 65 human organs. Data from necropsies,21 analyzed using Oncomine tools,31
show selective expression in the esophagus and other stratiﬁed epithelia such as the oropharyngeal mucosa and skin
derivatives. (B) Relative expression of esophagus-active keratin genes in the human Barrett’s esophagus (BE) cell line series
(CP-A, CP-B, and CP-C) with increasing dysplasia. Results of quantitative reverse-transcription polymerase chain reaction
analysis are represented with respect to transcript levels in the immortalized human esophageal cell line EPC2-hTert.20 (C)
Relative expression of esophagus-speciﬁc TF mRNAs in human BE cell lines CP-A, CP-B and CP-C, expressed in relation to
levels in EPC2-hTert cells. (D) Fold-enriched expression of esophagus-speciﬁc TF mRNAs in fresh human esophageal
epithelial biopsy samples8 relative to areas of BE in the same patients. (E) Expression of esophagus-speciﬁc TFs and intestine-
speciﬁc genes in normal human esophagus and BE resection specimens. Data used22 were analyzed using Oncomine tools.
600 Sulahian et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6polymerase chain reaction (qRT-PCR) and a library con-
taining oligonucleotide primers speciﬁc to 1880 known and
putative TFs.18 Tissue-speciﬁc TFs were identiﬁed using the
comparative CT method.
19 To further determine the tissue
speciﬁcity (Figure 1D), other whole organs were harvested
from adult C57BL/6 mice.Cell Lines
We cultured CP-A (KR-42421), CP-B (CP-52731), and
CP-C (CP-94251) cells (American Type Culture Collection,Manassas, VA) in MCDB-153 medium (cat. no. M7403;
Sigma-Aldrich, St. Louis, MO) supplemented with 0.4 mg/mL
hydrocortisone, 20 ng/mL recombinant human epidermal
growth factor (cat. no. E9644; Sigma-Aldrich), 8.4 mg/L
cholera toxin (cat. no. H0135; Sigma-Aldrich), 20 mg/L
adenine (cat. no. A2786; Sigma-Aldrich), 140 mg/mL bovine
pituitary extract (cat. no. P1476; Sigma-Aldrich), ITS sup-
plement (cat. no. I1884; Sigma-Aldrich) (ﬁnal concentra-
tions: 5 mg/mL insulin, 5 mg/mL transferrin, 5 ng/mL
sodium selenite), 4 mM glutamine, and 5% fetal bovine
serum. EPC2-hTert cells20 were cultured in Keratinocyte-
November 2015 SOX15 Control of Stratiﬁed Epithelial Genes 601SFM medium (GIBCO/Life Technologies, Grand Island, NY)
supplemented with bovine pituitary extract and recombi-
nant human epidermal growth factor (GIBCO). Soybean
trypsin inhibitor (Sigma-Aldrich) was used to quench
trypsin activity during cell passage.Gene Analyses
Figures 2A, D, and E and selected other ﬁgures show
analyses of relative mRNA expression levels from published
studies of 65 adult human tissues,21 of human esophageal
biopsy specimens,8 and of human normal esophagus, BE,
602 Sulahian et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6and EAC samples.22 The data were reanalyzed with respect
to SOX15 using Oncomine tools (Compendia Bioscience, Ann
Arbor, MI; www.oncomine.com), considering all samples in
each data set. Genes signiﬁcantly associated with SOX15
were ranked on the basis of correlation values. Enriched
Gene Ontology terms were determined using DAVID tools
(http://david.abcc.ncifcrf.gov/).
We examined processed RNA-seq data from a Cancer
Genome Atlas (TCGA) study on stomach cancer,23 ﬁrst
isolating 30 CINþ tumors arising at the gastroesophageal
(G-E) junction or gastric cardia for unsupervised clustering
(Supplementary Figure 1). To this group we applied hier-
archical clustering (using hclust from the R package; http://
cran.r-project.org) on the 1000 most variable transcripts
normalized according to expression z-scores, followed by a
second hierarchic clustering on the set of 317 genes coex-
pressed with SOX15. To assess the speciﬁcity of SOX15
overexpression in tumors of the gastric cardia, we compared
with RNA-seq data from TCGA studies on colon24 and distal
gastric adenocarcinomas.23Experimental RNA Analyses
Total RNA was isolated using TRIzol (Invitrogen/Life
Technologies, Carlsbad, CA), treatedwith the RNeasyMini Kit
(Qiagen, Valencia, CA), and DNA was digested using Turbo
DNA-Free (Ambion/Life Technologies, Austin, TX). For qRT-
PCR analysis (Figure 1A–C, Figure 2B and C, etc. 1 mg of to-
tal RNA was reverse-transcribed with Superscript III First
Strand Synthesis System (Invitrogen), and cDNA was ampli-
ﬁed using SYBRGreen PCR Master Mix (Applied Biosystems,
Foster City, CA). RNA-seq libraries (the full data set is
deposited in the Gene Expression Omnibus with accession
number GSE62909) were prepared from 300 ng of total RNA
using TruSeq RNA Sample Preparation kits (Illumina, San
Diego, CA), and 75-base pair (bp) single-end sequences were
obtained on a NextSeq 500 instrument (Illumina). The reads
were aligned to human genome build Hg19 using TopHat
v2.0.6 (https://ccb.jhu.edu/software/tophat/index.shtml).
Expression levels of transcripts in duplicate samples were
calculated as fragments per kb per 106mapped reads (FPKM)
using Cufﬂinks v2.0.2 (http://cole-trapnell-lab.github.io/
cufﬂinks/), and differential expression was determined us-
ing CuffDiff (http://cole-trapnell-lab.github.io/cufﬂinks/Figure 3. (See previous page). Impact of SOX15 depletion on
esophageal transcriptome. The mRNAs expressed in human e
transcripts from 7 other postmortem organs,21 and mRNAs
compared against transcripts from fresh Barrett’s esophagus (
squamous esophagus-speciﬁc genes relative to that tissue. W
tively, with a signiﬁcant 114-gene overlap (P < .0001, chi-squa
highly related to stratiﬁed epithelia. (B) SOX15 mRNA depletio
infected with lentiviruses carrying SOX15-speciﬁc or a nonspec
quantitative reverse-transcription polymerase chain reaction 72
(C) Results of duplicate RNA-seq analysis of genes differentially
or control, nonspeciﬁc (x-axis) shRNAs. Grey dots mark differen
union (548 genes) or intersection (114) sets of esophagus-spec
(D) Fraction of esophagus-speciﬁc transcripts reduced upo
intersection-set genes) compared with ﬁve random sets of equa
table lists GO terms enriched among SOX15-dependent genescuffdiff/).25 Chi-square tests with 1 degree of freedom and
two-tailed P values were used to assess signiﬁcance. Log2
(FPKM þ 1) values for control and SOX15-depleted samples
were plotted to display differential expression.Depletion of SOX15 and Expression of
Biotin-Tagged SOX15
The cells were infected with lentiviruses generated from
the pLKO.1 vector (Open Biosystems/GE Dharmacon,
Huntsville, AL) carrying either a SOX15-targeting small
hairpin RNA (shRNA) (TGCCTGGCAGCTATGGCTCTT) or a
control, nonspeciﬁc shRNA that does not complement any
human gene and is not toxic to cultured human cells
(CCTAAGGTTAAGTCGCCCTCG). Human SOX15 cDNA was
cloned into the pUltra vector (cat. no. 24129; Addgene,
Cambridge, MA) together with cassettes for the T2A
sequence, biotin, and BirA-V5 (gift of Ben Ebert, Brigham &
Women’s Hospital, Boston, MA).
Chromatin Immunoprecipitation and
Chromatin Immunoprecipitation With
High-Throughput Sequencing
Cells were cross-linked with 2 mM disuccinimidyl gluta-
rate (catalog no. 20593; Pierce Biotechnology, Rockford, IL)
in PBS for 45 minutes, followed by 10 minutes with 1%
formaldehyde (Pierce Biotechnology) in PBS at room
temperature. Chromatin immunoprecipitation (ChIP) and
chromatin immunoprecipitation with high-throughput
sequencing (ChIP-seq) were performed as described previ-
ously elsewhere26 using a 30-mL slurry of streptavidin-
conjugated magnetic beads (cat. no. 65601; Invitrogen). We
used Cistrome tools (www.cistrome.org) to identify and
annotate TF binding sites, generate wiggle ﬁles and conser-
vation plots, identify enriched sequence motifs and linked
genes, and compare data across ChIP-seq libraries. Wiggle
traces were projected on the Integrative Genome Viewer
(www.broadinstitute.org/igv/).27 Functions of genes within
50 kb of SOX15 occupancy were determined using GREAT
(http://omictools.com/great-s1664.html).28 ChIP-seq data
are deposited in the Gene Expression Omnibus (GEO) data-
base with accession number GSE62909 (www.ncbi.nlm.nih.
gov/geo/).esophageal gene expression. (A) Delineation of the human
sophageal necropsy specimens (left) were compared against
present in fresh esophageal biopsy specimens (right) were
BE) and intestinal biopsies.8 Numbers in each box represent
e identiﬁed 362 and 300 esophagus-speciﬁc genes, respec-
re test). The top Gene Ontology (GO) terms in each case are
n in 3 representative experiments in which CPA cells were
iﬁc (NS) 21-bp shRNAs. Knockdown efﬁciency, assessed by
hours after infection, was >8- to 10-fold in every experiment.
expressed in CP-A cells treated with SOX15-speciﬁc (y-axis)
tial expression (log2 >1.5-fold, q < .05); genes present in the
iﬁc genes are represented by red and blue dots, respectively.
n SOX15 depletion (red, 548 union-set genes; blue, 114
l numbers of genes expressed in CP-A cells (grey bars). The
.
Figure 4. Genome-wide SOX15 occupancy and gene dependence in human esophageal cells. (A) Summary of chromatin
immunoprecipitation (ChIP) analysis for biotinylated SOX15 in CP-A cells, showing high sequence conservation and signiﬁcant
enrichment of a canonical SOX recognition motif ACAA(A/T)G among 4864 identiﬁed binding sites. SOX15 mainly binds DNA
far from promoters. (B) Gene Ontology (GO) terms enriched among the two nearest genes within 50 kb of SOX15-binding sites,
determined using GREAT.28 (C) Percentages of esophagus-speciﬁc genes (as determined in Figure 2A, red: union; blue:
intersection set) that bind SOX15 within 50 kb of the transcription start site (TSS), compared with ﬁve random gene sets of
equivalent size (grey bars, P < .0001). The table lists GO terms enriched among genes from the esophagus transcriptome that
lie within 50 kb of SOX15 binding sites. (D) SOX15 binding (orange dots) within 50 kb of genes expressed in SOX15-depleted
and control CP-A cells (grey dots, q < .05, as in Figure 2B). Dashed lines demarcate genes unaffected by SOX15 loss. (E)
Genes reduced or increased in SOX15-depleted cells are signiﬁcantly enriched for nearby SOX15 binding. Together with the
proportions of orange dots in D, the data imply direct SOX15 activation of many, and direct repression of fewer genes. (F)
Integrated Genome Viewer representation of esophageal gene KRT6A, showing SOX15 binding at the locus (top rows, blue,
ChIP-seq tags) and reduced expression in SOX15-depleted CP-A cells (bottom rows, grey, RNA-seq tags). Numbers represent
the height of the y-axis.
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We baked 4-mm-thick tissue parafﬁn sections overnight at
37C; they then were deparafﬁnized in xylenes, rehydrated,
and peroxidase activity was blocked with 1.5% H2O2 in
methanol for 10 minutes. Slides were treated with 0.01 M
citrate buffer, pH 6.0, in a pressure cooker at 120C for 30minutes for antigen retrieval, then transferred to Tris-
buffered saline. Sections were ﬁrst incubated with mouse
CDX2 Ab (clone CDX2-88, Biogenexmu392A-uc, 1:200) for 40
minutes, followed by Dako Envisionþ Mouse (Dako K4007;
Dako, Carpinteria, CA) secondary Ab for 30 minutes, and
developed with 3,30-diaminobenzidine (Dako). Sections were
Figure 5. SOX15 expression in esophageal adenocarcinomas (EACs). (A) Gene coexpression proﬁles for SOX15 (left) and
CDX2 (right) in a large collection of normal, Barrett’s esophagus (BE), and EAC epithelium.22 We found that 317 transcripts
correlated strongly (r >0.81) with SOX15 mRNA levels in normal esophagus and in approximately one-third of 75 EACs in this
series. The 100 most highly correlated genes are shown. (B) Gene Ontology (GO) term enrichment among these 317 SOX15-
coexpressed genes. (C) Top: Fraction of SOX15 coexpressed genes showing SOX15 occupancy (observed) within 50 kb
compared with the fraction expected for appropriate random gene sets of equal size. Bottom: Fraction of SOX15 coexpressed
genes affected by SOX15 depletion (observed) compared with the fraction expected among random gene sets of equal size.
(D) Ranges of SOX15 mRNA expression extracted from RNA-seq data on the Cancer Genome Atlas collection of cancers of
the gastric cardia, fundus/body, and antrum,23 or colon and rectum.24 Statistical signiﬁcance of the differences was deter-
mined by t-test.
604 Sulahian et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6then incubated with mouse KRT5 Ab (clone XM26, Leica NCL-
L-CK, 1:500) for 40 minutes, followed by PowerVision AP
mouse (catalog no. PV6110; Leica Biosystems, Buffalo Grove,
IL) secondary Ab for 30 minutes, developed with Permanent
Red, and counterstained with Mayer’s hematoxylin. To stain
resection specimens that carried areas of BE, slides were
treated with the same mouse KRT5 Ab, followed by Dako
EnvisionþMouse (DakoK4007) secondary Ab for 30minutes,
and developed with 3,30-diaminobenzidine (Dako).
Results
Identiﬁcation of Transcription Factors That Are
Speciﬁc to the Esophageal Epithelium and
Attenuated in Barrett’s Esophagus
To identify candidate regulators of esophageal squamous
identity, we ﬁrst examined epithelia isolated from different
regions of the mouse alimentary tract—esophagus, glan-
dular stomach, and intestine (duodenum)—with a goal to
identify TF mRNAs expressed selectively in the stratiﬁed
esophageal epithelium (Figure 1A). Among 1880 known andputative DNA-binding proteins, those showing 32-fold
higher expression in the intestinal mucosa included the
known intestinal factors Atoh1, Cdx1, Creb3l3, Hnf4g, and
Isx,29 underscoring the ﬁdelity of the experimental approach
(Figure 1B). Forty factors and 59 TF genes showed
considerably higher expression in esophageal cells, com-
pared with the gastric corpus and the intestine, respectively
(Figure 1A), and 21 TFs were common to the two
esophagus-speciﬁc groups (Figure 1B).
To exclude variability among mouse strains and to
assess speciﬁcity relative to nondigestive organs, we
measured expression of these 21 mRNAs in nine diverse
tissues from C57BL/6 mice, including the skin. Six TFs gave
consistent evidence of high tissue speciﬁcity (Figure 1C and
D). Sim2 (single-minded family bHLH transcription factor 2)
and Pax9 (paired box 9) showed the greatest speciﬁcity,
followed by Sox15 and Trim29 (tripartite motif containing
29), which showed some expression in murine skin. Addi-
tional data from 65 adult human tissues21 revealed robust
expression of each of these four TF mRNAs in the esoph-
agus, with varying levels in other stratiﬁed squamous
Figure 6. Bi-lineage gene expression in a subset of
esophageal adenocarcinomas (EACs). (A–B) High correla-
tion (r ¼ 0.97) of SOX15 and KRT5 mRNAs in normal
esophagus, Barrett’s esophagus (BE), and EAC, validating
KRT5 as a proxy for SOX15 and other stratiﬁed epithelium-
speciﬁc genes. (B) Table of IHC results for KRT5 and CDX2
in 99 cases of EAC. (C–D) Representative immunohisto-
chemistry for KRT5 (red, a surrogate marker for SOX15 and
other squamous-speciﬁc gene products) and CDX2 (brown, a
representative intestine-speciﬁc marker) in two separate
cases (C and D) of human EAC. High KRT5 expression is
evident, with almost mutually exclusive distribution of KRT5
(þþ to þþþ) and CDX2 (þþþ to þþþþ) in the same ma-
lignant glands. Original magniﬁcations: Top, 200; Bottom,
400. (E) Absence of KRT5 immunostaining in areas of BE.
Adjoining areas of normal stratiﬁed epithelium provide a
positive control and contrast. IHC, immunohistochemistry.
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rivatives (Figure 2A).
To determine whether these TFs may function in the
identity of stratiﬁed epithelia, we examined expression data
from immortalized EPC2-hTert esophageal keratinocytes20
and found high expression of each factor except ELF5
(data not shown). Next we tested a series of three cell lines:
CP-A, which represents nondysplastic BE, and CP-B and CP-
C, which represent BE with high-grade dysplasia. This cell
line series replicates disease progression30 with reduced
levels of multiple keratin mRNAs (Figure 2B).
We observed a concomitant decline in SOX15 and
TRIM29 levels, matching or exceeding that of TP63 mRNA,
with little variance in the other factors (Figure 2C). Although
these ﬁndings do not in isolation give robust information
about a relation to mucosal dysplasia per se, they reveal the
squamous cell speciﬁcity of SOX15 and TRIM29. Further-
more, gene expression data from a collection of human
esophageal biopsy specimens8 showed signiﬁcantly fewer
SOX15 and TRIM29 mRNAs in primary BE compared with
adjacent normal esophageal mucosa (Figure 2D).
Finally, we used Oncomine tools31 to analyze mRNA data
from an independent series of 28 frozen human normal
esophagus and 15 frozen BE biopsy specimens.22 Levels of
PAX9, SOX15, and TRIM29 were uniformly high in normal
esophagus and attenuated in BE specimens (Figure 2E).
Together, these data identify SOX15, PAX9, and TRIM29
as conserved candidate determinants of squamous cell
identity. PAX9 levels were similar in CP-A, CP-B and CP-C
cells (Figure 2C), and although TRIM29 has a putative
DNA-binding domain, its role in transcriptional regulation is
poorly deﬁned and uncertain.32 By contrast, SOX proteins
control differentiation of diverse tissues, often in conjunc-
tion with other family members,33 and related factors such
as SOX2 and SOX7 are known to regulate aspects of
esophageal organogenesis and squamous cell cancer.13,14
We therefore concentrated on human SOX15, which shares
85% homology (100% in the DNA-binding domain) with the
mouse protein. SOX15 was previously noted as one among
hundreds of genes in various expression proﬁling stud-
ies,34–36 and we proceeded to investigate its functions.SOX15 Depletion Affects Genes Speciﬁc to
Stratiﬁed Epithelium
To test whether SOX15 might regulate genes speciﬁc to
the stratiﬁed human esophageal epithelium, we needed to
delineate the corresponding transcriptome. To this end, ﬁrst
we considered public data from adult human postmortem
tissues21 (see Figure 2A) and identiﬁed 362 genes that ex-
press at greater than threefold higher levels (P < .05) in the
esophagus than in any of seven diverse tissues, including
glandular stomach, from the same collection of postmortem
samples (Figure 3A). Second, we identiﬁed 300 genes with
greater than threefold higher mRNA levels (P < .05) in
normal fresh human esophagus biopsy specimens than in
adjacent areas of BE or in fresh intestinal biopsies from the
same study.8 Consistent with speciﬁc roles in stratiﬁed
epithelia, both gene sets were highly enriched for functions
606 Sulahian et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6related to ectodermal, epidermal, and keratinocyte differen-
tiation, and they shared 114 genes (Figure 3A). Accordingly,
we regard the union set of 548 genes as a good representation
of human esophagus-speciﬁc transcripts and the intersection
set of 114 genes as an especially robust subset.
To determine whether SOX15 regulates any part of this
transcriptome, we used lentiviral delivered shRNA to deplete
the TF in CP-A cells. These cells express keratin and TF genes
speciﬁc to stratiﬁed epithelia, including SOX15, at levels
similar to immortalized EPC2-hTert esophageal epithelial
cells (Figure 2B and C), and they tolerate lentiviral infection
and drug selection. Because SOX15 depletion retarded CP-A
cell growth and survival, we harvested cells 72 hours after
infection, when they appeared healthy but the SOX15 mRNA
levels were appreciably reduced (Figure 3B).
RNA-seq analysis showed reduced and increased levels
of 2950 and 717 transcripts, respectively, compared with
cells treated with a nonspeciﬁc shRNA (Figure 3C). In
agreement with the deﬁcit in cell growth, these genes were
enriched for Gene Ontology terms related to the cell cycle
(Supplementary Table 1). More importantly, genes reduced
in SOX15-depleted cells included 26.4% of the human
esophagus-speciﬁc “union” transcriptome, compared with
15.34% overlap with multiple sets of 2950 random genes
expressed in CP-A cells (Figure 3D; P < .0001). Corre-
spondence was even higher for the esophagus-speciﬁc
“intersection” transcriptome, where 31.5% of genes were
reduced in SOX15-depleted cells compared with 14.68% of
random genes (P < .0001). SOX15-dependent genes were
highly enriched for functions related to stratiﬁed epithelia
(Figure 3D). None of the 114 genes in the esophagus-speciﬁc
“intersection set,” and only 23 genes in the “union set” were
increased in SOX15-depleted CP-A cells, and we observed no
increase in intestinal genes. Rather, the 717 increased
transcripts were enriched for functions such as apoptosis
and vesicular transport (Supplementary Table 1). Thus,
beyond cell survival or proliferation, a substantial portion of
the esophageal transcriptome depends on SOX15.SOX15 Directly Regulates Esophagus-Speciﬁc
Genes
Depletion of SOX15 could affect transcript levels as a
consequence of its cis-regulatory activity or indirectly. To
determine whether SOX15 might regulate dependent genes
directly, we used ChIP-seq to map its cistrome. Because
available antibodies performed poorly in ChIP assays, we
expressed biotin-tagged SOX15 stably in CP-A cells and
precipitated chromatin using streptavidin beads. The nearly
5000 high-conﬁdence binding sites we identiﬁed by this
approach showed high sequence conservation and greatest
enrichment for the SOX consensus motif, which was present
in >97% of sites, implying direct TF occupancy (Figure 4A).
Similar to other tissue-speciﬁc TFs, SOX15 occupied few
promoters (6.2% of all binding sites) and bound DNA pre-
dominantly in intergenic regions and introns (Figure 4A).
GREAT analysis28 of the nearest ﬂanking genes within 50
kb of SOX15 occupancy revealed enrichment of pathways
known to be vital in stratiﬁed epithelia, such as epidermalgrowth factor and Rho/Rac signaling, and in cell survival
(Figure 4B). Moreover, 20.9% of genes in the human
esophagus-speciﬁc transcriptome and 31.5% of genes
common to the two esophagus transcript sources showed at
least one SOX15-binding site within 50 kb of the tran-
scription start site, compared with about 5% of comparable
numbers of random genes (P < .0001, Figure 4C).
Gene Ontology terms related to stratiﬁed epithelia were
further enriched among SOX15-bound genes (Figure 4C).
Most importantly, genes affected by SOX15 depletion in CP-A
cells were highly enriched for nearby SOX15 binding,
compared with random gene sets of equal size (P < .0001),
and SOX15-bound genes reduced in SOX15-depleted cells far
outnumbered genes that were increased (Figure 4D and E).
Taken together, these data indicate direct SOX15 regu-
lation of genes speciﬁc to the stratiﬁed squamous epithe-
lium, with a strong bias toward gene activation. Canonical
esophageal genes such as KRT6A (keratin 6A, type II)
illustrate SOX15 occupancy at putative cis-regulatory sites
and reduced expression in SOX15-depleted cells (Figure 4F).SOX15 in Human Esophageal Adenocarcinoma
SOX15 is expressed highly in normal human esophagus,
but not in the BE cell lines CP-B and CP-C (Figure 2C) or in
areas of intestinal metaplasia in vivo (Figure 2D and E). To
our surprise, RNA expression data from a large collection of
frozen primary esophagus, BE, and EAC biopsy specimens22
revealed high SOX15 mRNA levels in up to one-third of EACs
(Figure 3A, left; note that all samples in this study, including
EAC, were frozen biopsy specimens). Moreover, at least 317
transcripts that are strongly coexpressed with SOX15 in the
normal esophagus (r > 0.81; Supplementary Table 2) were
also present in the same EAC specimens (Figure 5A, which
shows the 100 genes with highest correlation), suggesting
broad activation of the squamous cell transcriptional
program.
Accordingly, functions related to stratiﬁed epithelia were
signiﬁcantly enriched among the genes coexpressed with
SOX15 (Figure 5B). The canonical intestinal marker CDX2
and its coexpressed genes (r > 0.81) were expressed in
many SOX15þ and also in SOX15 specimens (Figure 5A,
right), revealing coexpression of esophageal and intestinal
genes in some cases. Moreover, 21.6% of genes coexpressed
with SOX15 in this analysis showed SOX15 binding within
50 kb in CP-A cells, compared with w6% of random genes
(P < .0001; Figure 5C, top), which implies that many of
these genes are direct transcriptional targets. Indeed, the
effects of SOX15 depletion were statistically signiﬁcantly
greater on these genes than on random sets of genes
expressed in CP-A cells (P < .017; Figure 5C, bottom). These
features collectively suggest direct SOX15 regulation of
many esophagus-restricted genes that are silent in BE and
reactivated in up to one-third of human EACs.
To exclude the possibility that EACs expressing SOX15
were simply contaminated with normal SOX15þ esophageal
cells, we studied cases from an independent collection, the
Cancer Genome Atlas (TCGA), where nonmalignant cells
were meticulously minimized.23 Cancers of the G-E junction
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with chromosomal instability (CIN), usually represent distal
EACs. Among 30 cases of CINþ tumors from the G-E junc-
tion or gastric cardia in the TCGA collection of gastric can-
cers, some samples showed robust levels of SOX15 and of
genes coexpressed with SOX15 in normal esophageal
epithelium (Supplementary Figure 1A and B). Transcripts
speciﬁc to the squamous esophageal epithelium were thus
again evident in a fraction of EACs. To determine whether
this extent of SOX15 expression is speciﬁc to EACs, we
evaluated other gastrointestinal cancers in the TCGA
collection: gastric fundus, body, and antrum, and colorectal
tumors. Extreme outliers for SOX15 mRNA expression were
present only among tumors of the gastric cardia (Figure 5D).
Finally, we examined 99 separate EACs by immunohis-
tochemistry on resection specimens. Because several anti-
bodies failed to detect SOX15, we used KRT5 (keratin 5, type
II) as a proxy for expression of SOX15 and other stratiﬁed
cell-speciﬁc products, noting nearly total concordance of
SOX15 and KRT5 mRNA expression in the large aforemen-
tioned tissue collection22 (Figure 6A; r ¼ 0.97). We also
stained the same samples for the intestinal marker CDX2.
Nineteen cases (19%) showed cytoplasmic KRT5 expression
within malignant glands, and most of these cases coex-
pressed nuclear CDX2 (Figure 6B). Levels of KRT5 were
variable (Figure 6B) but did not correlate with tumor grade
or other pathologic features such as mucin production.
Importantly, KRT5 was not expressed in rare pockets of
squamous differentiation but rather in bona ﬁde glandular
structures. In fact, and of particular note, cytoplasmic KRT5
and nuclear CDX2 were almost always present in different
cells within the same glands (see Figures 6C and D for
examples from two different cases). Coexpression of
esophagus- and intestine-speciﬁc genes within individual
glands reveals the malignant cells’ potential to express
genes from distinct cell lineages.
To corroborate the observation that mRNA levels of
stratiﬁed cell genes are low in BE but elevated in many EACs
(Figures 5A and 6A), we used immunohistochemistry to
assess areas of BE that were present in 24 of the 99 resection
specimens. KRT5 was uniformly absent from these areas,
though the signal was clear in adjoining stratiﬁed epithelium
(Figure 6E). These ﬁndings extend previous reports of absent
expression of stratiﬁed epithelium-speciﬁc keratins in
BE37–39 and low-level expression of squamous cell products
in EACs.40 Our delineation of a squamous cell-restricted
transcriptome (Figure 3A), coupled with reanalysis of pub-
lished RNA expression data (Figure 5A and B) and investi-
gation of additional cases by immunohistochemical analysis
(Figure 6B–D), reveals for the ﬁrst time the extent and
breadth of an aberrant stratiﬁed-cell program in EACs.
Discussion
Implications for Esophageal Squamous
Differentiation and Esophageal Adenocarcinoma
Insights into transcriptional control of the esophageal
squamous epithelium are largely limited to the broad
functions of TP63 and SOX2.10,13 Our identiﬁcation of SOX15as a novel, conserved, and likely direct regulator of many
human stratiﬁed epithelial genes extends our understanding
of esophageal differentiation and pathology. The lack of
overt esophageal defects in Sox15 mutant mice41,42 is
compatible with the considerable known redundancies
among SOX-family TFs.33
There is much debate whether BE and particularly EAC
originate in the native esophageal epithelium through bona
ﬁde metaplasia or in ectopic cells that may colonize the
esophagus from the gastric cardia, as in mice.11,43 Clearly,
the best way to answer the question is through lineage-
tracing studies, which are possible in animals but not in
humans. When lineage tracing is not feasible, cell-speciﬁc
transcript patterns offer clues, and the expression of
SOX15 and other squamous epithelial genes may be infor-
mative. Consider, for example, the observation that the BE
cell lines CP-A/B/C show reduced levels of SOX15, esopha-
geal keratins, TP63, and other esophagus-speciﬁc TF genes,
implying loss of an esophageal program, but some
esophagus-restricted TF genes such as SIM2 and TFAP2A
(transcription factor activating enhancer binding protein
2a) are highly expressed in these cells (Figure 2C) and in BE
biopsy specimens (Figure 2D and E). Moreover, >300
esophageal genes, including SOX15, are active in up to 30%
of human EACs (Figure 3A), with intestinal genes such as
CDX2 often coexpressed in the same glands as esophageal
genes (Figure 4C and D). These ﬁndings in BE and EAC could
indicate residual squamous cell-speciﬁc transcription or
fortuitous ectopic gene activity. If diseased cells are better
equipped to express genes from their native transcriptional
program than are genes from a heterologous cell lineage,
because native genes and their cis-regulatory elements are
inherently primed and accessible, then the ﬁrst possibility
may be more likely. Our ﬁndings do not of course rule out
the alternative model, which will require additional, inde-
pendent lines of evidence.
EAC is a particularly recalcitrant disease, with poor
5-year survival rates. Surgery and empiric cytotoxic
chemotherapy anchor current treatment approaches,44,45
and although disease heterogeneity is apparent in the
clinic, the underlying determinants are unclear. We show
here that one-ﬁfth to one-third of EACs simultaneously ex-
press products speciﬁc to the esophageal squamous
epithelium and columnar intestinal cells. It will be impor-
tant in the future to identify the clinical and genetic corre-
lates of these EACs showing bi-lineage gene expression and
to determine whether they reﬂect a distinctive pathophys-
iology or harbor unique therapeutic vulnerabilities.
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Supplementary
Figure 1. Genes coex-
pressed with SOX15 in
the Cancer Genome Atlas
(TCGA) data set of gas-
tric cancers. (A) Correla-
tions of all mRNAs with
SOX15 levels. The 317
genes coexpressed with
SOX15 in esophageal epi-
thelium are marked with red
lines. (B) Expression of
SOX15 coexpressed genes
in 30 cases of CINþ (chro-
mosomal instability) ade-
nocarcinomas from the
gastroesophageal junction
or gastric cardia.
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Supplementary Table 1.Top Gene Ontology (GO) terms for transcripts altered after SOX15 depletion in CPA cells
Term RNAseq Down P Value Term RNAseq UP P Value
GO:0000278 w mitotic cell cycle 3.26E20 GO:0000079 w regulation of cyclin-dependent
protein kinase activity
4.40E06
GO:0051301 w cell division 6.39E20 GO:0016192 w vesicle-mediated transport 6.89E06
GO:0000280 w nuclear division 1.39E19 GO:0051726 w regulation of cell cycle 8.53E06
GO:0007067 w mitosis 1.39E19 GO:0009991 w response to extracellular stimulus 3.09E05
GO:0022403 w cell cycle phase 1.48E19 GO:0006091 w generation of precursor metabolites
and energy
5.73E05
GO:0000087 w M phase of mitotic cell cycle 1.52E19 GO:0045767 w regulation of antiapoptosis 7.05E05
GO:0022402 w cell cycle process 4.58E19 GO:0031667 w response to nutrient levels 1.71E04
GO:0007049 w cell cycle 2.49E18 GO:0007584 w response to nutrient 2.63E04
GO:0000279 w M phase 2.96E18 GO:0008219 w cell death 5.87E04
GO:0048285 w organelle ﬁssion 3.08E18 GO:0010033 w response to organic substance 6.29E04
GO:0007059 w chromosome segregation 1.93E10 GO:0042981 w regulation of apoptosis 6.32E04
GO:0008104 w protein localization 4.68E10 GO:0055114 w oxidation reduction 6.36E04
GO:0045184 w establishment of protein localization 5.39E10 GO:0042127 w regulation of cell proliferation 6.77E04
GO:0008654 w phospholipid biosynthetic process 6.48E10 GO:0016265 w death 6.77E04
GO:0015031 w protein transport 2.46E09 GO:0043067 w regulation of programmed cell death 7.56E04
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Supplementary Table 2.Genes Coexpressed With SOX15
in a Large Collection of Primary
Esophagus, Barrett’s Esophagus,
and Esophageal Adenocarcinoma
Specimens (r > 0.81)
Gene Correlation With SOX15 Expression
SOX15 1.000
GRHL3 0.981
FAM46B 0.981
ZNF750 0.981
LYPD3 0.981
CAPNS2 0.979
IL20RB 0.978
BNIPL 0.978
ANXA8L2 0.975
GPR87 0.971
TMPRSS11D 0.971
LY6D 0.971
LASS3 0.971
CLCA2 0.971
PKP1 0.971
KRT5 0.971
GSDMC 0.970
TMEM40 0.970
FAM83C 0.970
TP63 0.970
DSC3 0.970
TGM5 0.964
TMPRSS11A 0.964
GJB6 0.964
KLK13 0.964
LYNX1 0.964
SPINK5 0.961
ENDOU 0.961
RNF222 0.961
PRSS27 0.961
KRT78 0.961
CRCT1 0.961
SCEL 0.961
A2ML1 0.961
SLURP1 0.961
c9orf169 0.961
CSTA 0.961
MAL 0.961
KRT6C 0.961
ARHGAP6 0.961
DSG3 0.961
TGM1 0.961
SBSN 0.961
SPRR1B 0.961
CLCA4 0.961
CALML3 0.961
RHCG 0.961
Supplementary Table 2.Continued
Gene Correlation With SOX15 Expression
KRT4 0.961
SERPINB13 0.961
GBP6 0.961
NCCRP1 0.961
TMRSS11B 0.961
CNFN 0.961
TGM3 0.961
CRNN 0.961
HSPB8 0.961
SERPINB2 0.961
S100A2 0.961
LGALS7B 0.952
LGALS7 0.952
DUOX1 0.949
DUOXA1 0.949
CSNK1E 0.944
CLIC3 0.942
HOPX 0.940
SERPINB4 0.939
SERPINB3 0.939
ECM1 0.937
Trim29 0.937
SLC39A2 0.937
RAET1G 0.937
AQP3 0.937
TMEM154 0.937
GNA15 0.937
SULT2B1 0.937
ALDH3B2 0.937
EVPL 0.937
GRHL1 0.937
KAZ 0.937
PITX1 0.937
TMEM79 0.937
DENND2C 0.937
VSIG10L 0.937
ZNF185 0.937
PPL 0.937
GJB5 0.937
KRT15 0.937
c10orf99 0.931
EPHX3 0.928
AIF1L 0.928
CRABP2 0.928
PPP1R3C 0.917
ZNF365 0.916
CPA4 0.916
SPINK7 0.916
RNASE7 0.916
LOC643479 0.916
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Gene Correlation With SOX15 Expression
TIAM1 0.912
ARL4D 0.912
LASS4 0.912
IVL 0.912
P2RY1 0.912
DLK2 0.912
ANXA8 0.912
BBOX1 0.911
CYP4F22 0.911
SCNN18 0.911
MUC15 0.911
CWH43 0.911
CALML5 0.909
CST6 0.906
FAM83A 0.904
CDA 0.904
KRT80 0.904
LYPD2 0.901
FGF11 0.899
PPP2R2C 0.899
TLE3 0.881
DOCK9 0.881
PLD2 0.881
PYGL 0.881
BNIP3 0.881
TUBB6 0.881
NDUFA4L2 0.881
BDKRB1 0.881
NDRG4 0.881
CBR3 0.881
SLC22A17 0.881
SRPX2 0.881
FRMD6 0.881
MID2 0.881
EFS 0.881
PARD6G 0.881
c3orf54 0.881
RGMA 0.881
RRAGD 0.881
ANKRD35 0.881
TNFAIP8L3 0.881
ELOVL4 0.881
CRYAB 0.881
GPC1 0.881
ZNF385A 0.881
WDFY2 0.881
NOD2 0.881
PTPN13 0.881
TFAP2C 0.881
CDK5R1 0.881
Supplementary Table 2.Continued
Gene Correlation With SOX15 Expression
VSNL1 0.881
MICALL1 0.872
PAK6 0.872
PVRL1 0.872
PVRL4 0.872
ITPKC 0.872
SPTBN2 0.872
SAMD9 0.872
AIM1L 0.872
PLCD1 0.872
NLRX1 0.872
MPZL2 0.872
PRRG4 0.872
PPP1R13L 0.872
URGCP 0.872
XG 0.863
HES2 0.863
c12orf54 0.863
IRX4 0.863
DST 0.863
BNC1 0.863
ARHGEF4 0.858
DMKN 0.855
KLK10 0.855
LTB4R 0.855
CYP2E1 0.853
KCTD1 0.852
ATP13A4 0.849
ATP6V0A4 0.849
RASGRP1 0.849
TRIM6 0.849
SHROOM2 0.849
CLIP4 0.849
KLK12 0.840
S100A8 0.840
S100A9 0.840
KRT6B 0.840
SPRR3 0.840
KRT13 0.840
SPRR1A 0.840
SPRR2A 0.840
NCKAP5 0.833
GPR1 0.833
CDKN2B 0.833
LOC653110 0.833
SFTPD 0.833
FBXO27 0.833
ZNF433 0.824
CA12 0.824
WNT4 0.824
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Supplementary Table 2.Continued
Gene Correlation With SOX15 Expression
MTSS1 0.824
WDR47 0.824
ELL2 0.824
RORA 0.824
SLC9A9 0.824
SEMA4A 0.824
MAF 0.824
BEX4 0.824
SERPINB8 0.824
ZDHHC21 0.824
ZNF425 0.824
SNX24 0.824
ALDH4A1 0.824
NOTCH2NL 0.824
DUSP22 0.824
MBD2 0.824
C4ORF3 0.824
CNOT1 0.824
CTTNBP2NL 0.824
CUL4B 0.824
ADK 0.824
MOSPD1 0.824
PDZD2 0.824
CAB39P 0.824
ZNF431 0.824
RASAL2 0.824
TMOD3 0.824
ARHGAP10 0.824
DAPP1 0.824
SLC2A6 0.824
ZNF426 0.824
RIT1 0.824
UBE2H 0.824
SPTLC1 0.824
KAT2B 0.824
SECISBP2L 0.824
KIAA1370 0.824
RNF11 0.824
WDR26 0.824
RANBP9 0.824
ABHD5 0.824
YOD1 0.824
SEPT10 0.824
UBE2G1 0.824
SASH1 0.824
GAB1 0.824
PARD3 0.824
RSC1A1 0.824
TPD52L1 0.824
IL34 0.824
Supplementary Table 2.Continued
Gene Correlation With SOX15 Expression
HRASLS 0.824
ESPL1 0.824
TRPS1 0.824
KCNG1 0.824
HSPA2 0.824
ABLIM3 0.824
FNDC4 0.824
VAT1 0.824
FLJ11235 0.824
DKK4 0.824
WWTR1 0.824
ATG9B 0.824
PADI3 0.824
SYNPO2L 0.824
TCP11L2 0.824
CCNG2 0.824
GPR110 0.824
SPINK8 0.824
GYS2 0.824
INPP5A 0.824
ILI2A 0.824
UPK1A 0.824
KCNK7 0.824
CYP4B1 0.824
SYNGR1 0.824
OGFRL1 0.824
SLC16A6 0.824
HLF 0.824
DLG2 0.824
CYP11A1 0.824
PTN 0.824
BARX2 0.824
CLDN8 0.824
RHOV 0.824
C1ORF161 0.824
SNX31 0.824
ACPP 0.824
S100A13 0.824
USH1G 0.824
GNG4 0.824
ADAMTSL4 0.824
SLC13A4 0.824
POU3F1 0.824
IL1RN 0.824
IL1F6 0.824
KLK11 0.824
MREG 0.824
ZBED2 0.824
CALB2 0.824
ALOX12 0.824
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Supplementary Table 2.Continued
Gene Correlation With SOX15 Expression
CRISP3 0.824
EHD3 0.824
ACYP2 0.824
C2ORF54 0.824
KLF8 0.824
KREMN1 0.824
TPRG1 0.824
PAX9 0.824
SUSD4 0.824
DAPL1 0.824
ARSF 0.816
ALOX15B 0.816
C18ORF26 0.816
FMO2 0.816
FAM63A 0.806
SH3GL3 0.806
LY6G6C 0.806
DSG1 0.806
CLDN17 0.806
KPRP 0.806
IGFL1 0.806
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